Corrigendum to: Gestational trophoblastic neoplasia, FIGO 2000 staging and classification (International Journal of Gynecology & Obstetrics, (2003), 83, S1, (175-177), 10.1016/s0020-7292(03)90120-2);Gestational trophoblastic neoplasia, FIGO 2000 staging and classification

International Journal of Gynecology and Obstetrics

Volumn 83, Issue SUPPL. 1, 2003, Pages 175-177

  Ngan, H Y S ^a   Bender, H ^b   Benedet, J L ^b   Jones, H ^b   Montruccoli, G C ^b   Pecorelli, S ^b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CANCER STAGING; HUMAN; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY; TROPHOBLASTIC TUMOR; WORLD HEALTH ORGANIZATION; CLASSIFICATION; FEMALE; PATHOLOGY;

FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; NEOPLASM STAGING;

EID: 10644245919     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1002/ijgo.13970     Document Type: Erratum

References (14)

1. Song HC, Wu PC, Tong MY, Wang YO. Trophoblastic Tumours Diagnosis and Treatment. People Health, Beijing, 128-129. 1981. Ref Type: Generic
2. Gestational trophoblastic diseases. Report of a WHO Scientific Group. World Health Organ Tech. Rep. Ser. 1983; 692:7-81.
3. Bagshawe KD. Risk and prognostic factors in trophoblastic neoplasia. Cancer 38, 1373-1385. 1976. Ref Type: Generic
4. FIGO Oncology Committee Report. Int. J. Gynaecol. Obstet. 39, 149-150. 1992. Ref Type: Generic
5. Goldstein DP, Zanten-Przybysz IV, Bernstein MR, Berkowitz RS. Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy. J. Reprod. Med. 1998; 43:37-43.
6. Ma H, Wong LC, Ngan HY. Staging and classification. In: Gestational Trophoblastic Disease, Hancock BW, Newlands E, Berkowitz R, eds. London: Chapman and Hall, 1997; 95-108.
7. Bower M, Newlands ES, Holden L, Short D, Brock C, Rustin GJ et al. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J. Clin. Oncol. 1997; 15:2636-43.
8. Kim SJ, Bae SN, Kim JH, Kim CT, Han KT, Lee JM et al. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT - 25 years experiences of KRI-TRD. Int. J. Gynaecol. Obstet. 1998;60 Suppl 1: S85-S96.
9. Lurain JR, Casanova LA, Miller DS, and Rademaker AW. Prognostic factors in gestational trophoblastic tumors: a proposed new scoring system based on multivariate analysis. Am. J. Obstet. Gynecol. 164, 611-616. 1991. Ref Type: Generic
10. Ngan HY, Lopes AD, Lauder IJ, Wong LC, Ma HK. An evaluation of the prognostic factors in metastatic gestational trophoblastic disease. Int. J. Gynaecol. Obstet. 36, 36-42. 1994. Ref Type: Generic
11. Azab MB, Pejovic MH, Theodore C et al. Prognostic factors in gestational trophoblastic tumors: A multivariate analysis. Cancer 62, 585-592. 1988. Ref Type: Generic
12. Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int. J. Gynecol. Cancer 2001; 11:73-77.
13. Kohorn EI, Goldstein DP, Hancock BW, Kim SJ, Lurain JR, Newlands E et al. Workshop Report: Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Heath Organization for Trophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society. Int. J. Gynecol. Cancer 2000; 10:84-88.
14. FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Committee on Gynecologic Oncology. Int. J. Gynecol. Obstet. 2002; 77:285-87.